Evaluation of pretreatment laboratory studies for lenalidomide, bortezomib, and dexamethasone in patients with multiple myeloma

Eva Huang, Providence
Anhthy Tong, Providence
Ian Ingram, Providence
Robert Grabowski, Providence

Description